RC
EGRX

RBF Capital’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

RBF Capital’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-143,078
Closed -$534K – 613
2024
Q3 		$534K Buy
143,078
+14,991
+12% +$55.9K 0.03% 398
2024
Q2 		$717K Buy
+128,087
New +$717K 0.04% 323